Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$5.48
+0.1%
$5.49
$3.80
$10.77
$23.76M-0.948,236 shs1,732 shs
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.33
-14.8%
$0.32
$0.25
$1.19
$17.03M1.19173,401 shs4.12 million shs
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$1.96
+4.8%
$1.68
$1.32
$7.66
$20.65M2.42191,442 shs324,854 shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.38
-1.1%
$1.35
$0.42
$1.68
$23.75M4.6617,675 shs6,568 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
+0.27%+4.21%+3.85%-23.33%-20.20%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00%0.00%0.00%0.00%-70.98%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
+12.52%+23.84%+8.09%-11.37%-96.80%
Marpai, Inc. stock logo
MRAI
Marpai
-4.14%-4.14%+6.11%+3.73%+195.74%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/AN/AN/AN/AN/AN/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
0.6 of 5 stars
0.02.00.00.03.61.70.0
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
0.00
N/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00
N/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
0.00
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$52.60M0.45N/AN/A$51.05 per share0.11
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$29.09M0.59N/AN/A$1.09 per share0.30
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$516.03K40.02N/AN/A$1.83 per share1.07
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.68N/AN/A($1.72) per share-0.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-$42.23MN/A0.00N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
-$26.08MN/A0.00N/A-75.34%-7.96%-5.49%N/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-$8.71M-$3.86N/AN/A-2,757.86%-85.01%-78.08%N/A
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$0.87N/AN/A-85.70%N/A-100.23%11/11/2025 (Estimated)

Latest MGRX, CCM, MRAI, and ENZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A-$0.57N/A-$0.57N/A$0.17 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.40123.08%N/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
1.67
0.46
0.45
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A
2.55
2.28
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A
0.07
0.07
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82

Institutional Ownership

CompanyInstitutional Ownership
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
36.90%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
56.72%
Marpai, Inc. stock logo
MRAI
Marpai
49.75%

Insider Ownership

CompanyInsider Ownership
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
46.50%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
11.40%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
16.00%
Marpai, Inc. stock logo
MRAI
Marpai
46.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
9704.34 million2.32 millionNot Optionable
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
52052.40 million46.29 millionOptionable
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
310.54 million8.85 millionNot Optionable
Marpai, Inc. stock logo
MRAI
Marpai
15017.27 million5.61 millionNo Data

Recent News About These Companies

Marpai, Inc. Reports Significant Q2 2025 Turnaround
Marpai, Inc. (MRAI) Q2 2025 Earnings Call Transcript
MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Marpai, Inc. Reports Q1 2025 Financial Results
Marpai, Inc. (MRAI) Q1 2025 Earnings Call Transcript
Marpai appoints new COO to accelerate growth
Market Access RICI Agriculture UCITS (MRAI)
Marpai, Inc. (MRAI) Q4 2024 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Concord Medical Services stock logo

Concord Medical Services NYSE:CCM

$5.48 +0.01 (+0.09%)
Closing price 03:50 PM Eastern
Extended Trading
$5.48 0.00 (0.00%)
As of 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Enzo Biochem stock logo

Enzo Biochem NYSE:ENZ

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Mangoceuticals stock logo

Mangoceuticals NASDAQ:MGRX

$1.96 +0.09 (+4.81%)
Closing price 04:00 PM Eastern
Extended Trading
$1.97 +0.01 (+0.51%)
As of 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.38 -0.02 (-1.08%)
As of 03:49 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.